Literature DB >> 8891823

Pyoderma faciale: manifestation of inflammatory bowel disease.

M W Dessoukey1, M F Omar, H A Dayem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8891823     DOI： 10.1111/j.1365-4362.1996.tb00647.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  4 in total

1.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

Review 2.  Review.

Authors:  Vikas Pabby; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

3.  Successful treatment of localized pyoderma faciale in a patient with Crohn's disease.

Authors:  Sanam Razeghi; Christian R Halvorson; Anthony A Gaspari; Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

Review 4.  A causal association between isotretinoin and inflammatory bowel disease has yet to be established.

Authors:  Seth D Crockett; Ajay Gulati; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2009-10       Impact factor: 10.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.